Integrated CRISPR screening and drug profiling identifies combination opportunities for EGFR, ALK, and BRAF/MEK inhibitors
Titel:
Integrated CRISPR screening and drug profiling identifies combination opportunities for EGFR, ALK, and BRAF/MEK inhibitors
Auteur:
Tiedt, Ralph King, Frederick J. Stamm, Christelle Niederst, Matthew J. Delach, Scott Zumstein-Mecker, Sabine Meltzer, Jodi Mulford, Iain J. Labrot, Emma Engstler, Barbara Schacher Baltschukat, Sabrina Kerr, Grainne Golji, Javad Wyss, Daniel Schnell, Christian Ainscow, Edward Engelman, Jeffrey A. Sellers, William R. Barretina, Jordi Caponigro, Giordano Porta, Diana Graus